Loading…
Medical Laboratory Personnel Shortage Relief Act of 2025
Legislative Progress
Introduced
September 17, 2025
Latest Action
September 17, 2025
Primary Sponsor
Deborah K. RossDemocratic(NC)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 10,940 other HR bills in the 119th — cohort avg 30d
Medical Laboratory Personnel Shortage Relief Act of 2025 This bill adds medical laboratory professionals to the National Health Service Corps (NHSC) and establishes a grant program to fund education programs for medical laboratory professionals. Specifically, it makes medical laboratory professionals eligible to participate in the NHSC, which provides scholarships and student loan repayment awards to health care providers who agree to work in areas with health care provider shortages. The bill also authorizes the Department of Health and Human Services to award grants to, or enter into contracts with, certain hospitals, schools, and nonprofits to develop and operate accredited education programs that award degrees or certificates to medical laboratory professionals.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2026 · third_quarter · Health Issues
H.R. 5444 - Medical Laboratory Personnel Shortage Relief Act of 2025 H.R. 7961 - Physicians and Healthcare Workforce Act S. 2355/H.R. 5582 - Patients Deserve Price Tags Act H.R. 9393 - Lower Costs, More Transparency Act of 2026 Federal policies related to prior authorization for medical services S.1816/H.R. 3514 - Improving Seniors Timely Access to Care Act of 2025 H.R. 8890 - The Enhancing Clinical Laboratory Innovation and Access (Enhancing CLIA) Act of 2026 H.R. 8413 - SECURE Data Act CMS HealthTech Ecosystem and Interoperability AI policies related to health care
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $300,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Health Issues
Healthcare issues related to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 5582/S. 2355, the Patients Deserve Price Tags Act, H.R. 9393, the Lower Costs, More Transparency Act, and H.R. 9645, the Health Care Price Certainty for All Americans Act, provisions relating to lab test price transparency; H.R. 9117, the Clear Healthcare Expense Cost Knowledge (CHECK) Act, provisions relating to administrative service provider price transparency and itemized patient billing; S. 3097, the Health Information Privacy Reform Act, provision relating to privacy of health data; H.R. 8500, the Timely Access to Coverage Decisions Act, provisions relating to establishment of standards for Medicare local coverage decisions; H.R. 8890, the Enhancing Clinical Laboratory Innovation and Access (Enhancing CLIA) Act, provisions relating to oversight of laboratory-developed tests; H.R. 6130/S. 3267, the Alzheimers Screening and Prevention (ASAP) Act, provisions relating to Medicare coverage of blood-based dementia screening tests; H.R. 5444, the Medical Laboratory Personnel Shortage Relief Act, provisions relating to amending the Public Health Service Act to address the shortage of medical laboratory personnel; Federal policy relating to prior authorization and oversight of laboratory benefit managers; Federal policy relating to access to mandatory code sets for administrative transactions; and Federal policy relating to supply chain issues affecting pre-clinical biomedical research for drug development.
Client expense: $250,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Health Issues
H.R. 5444 - Medical Laboratory Personnel Shortage Relief Act of 2025 H.R. 7961 - Physicians and Healthcare Workforce Act S. 2355/H.R. 5582 - Patients Deserve Price Tags Act H.R. 9393 - Lower Costs, More Transparency Act of 2026 Federal policies related to prior authorization for medical services S.1816/H.R. 3514 - Improving Seniors Timely Access to Care Act of 2025 H.R. 8890 - The Enhancing Clinical Laboratory Innovation and Access (Enhancing CLIA) Act of 2026 H.R. 8413 - SECURE Data Act CMS HealthTech Ecosystem and Interoperability AI policies related to health care
Client expense: $470,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Health Issues
Healthcare issues related to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; Federal policy relating to oversight of laboratory-developed tests; Section 71120 of H.R. 1, An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14, provisions relating to modifying cost sharing requirements for certain expansion individuals under the Medicaid program; H.R. 3514/S.1816, the Improving Seniors Timely Access to Care Act, provisions relating to prior authorization of services to Medicare Advantage beneficiaries; S. 2355, the Patients Deserve Price Tags Act, provisions relating to lab test price transparency; H.R. 5444, the Medical Laboratory Personnel Shortage Relief Act, provisions relating to medical laboratory personnel eligibility for the National Health Service Corps and federal grants for lab personnel training; Federal policy relating to implementation of Medicare reimbursement cuts under the Statutory Pay-As-You-Go Act of 2010, Pub. L. 111-139; and Federal policy related to supply chain issues affecting pre-clinical biomedical research for drug development.
Client expense: $260,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Health Issues
Healthcare issues related to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; Federal policy relating to oversight of laboratory-developed tests; Section 71120 of H.R. 1, An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14, provisions relating to modifying cost sharing requirements for certain expansion individuals under the Medicaid program; H.R. 5444, the Medical Laboratory Personnel Shortage Relief Act, provisions relating to medical laboratory personnel eligibility for the National Health Service Corps and federal grants for lab personnel training; and Federal policy relating to implementation of Medicare reimbursement cuts under the Statutory Pay-As-You-Go Act of 2010, Pub. L. 111-139;
Client expense: Not reported · Firm income: $110,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Health Issues
Healthcare issues related to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; Federal policy relating to oversight of laboratory-developed tests; Section 71120 of H.R. 1, An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14, provisions relating to modifying cost sharing requirements for certain expansion individuals under the Medicaid program; H.R. 3514/S.1816, the Improving Seniors Timely Access to Care Act, provisions relating to prior authorization of services to Medicare Advantage beneficiaries; S. 2355, the Patients Deserve Price Tags Act, provisions relating to lab test price transparency; H.R. 5444, the Medical Laboratory Personnel Shortage Relief Act, provisions relating to medical laboratory personnel eligibility for the National Health Service Corps and federal grants for lab personnel training; Federal policy relating to implementation of Medicare reimbursement cuts under the Statutory Pay-As-You-Go Act of 2010, Pub. L. 111-139; and Federal policy related to supply chain issues affecting pre-clinical biomedical research for drug development.
Client expense: $270,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE